Series D · Healthtech
Elucid raises $55M Series D, reaching about $185M total funding
Elucid raised $55 million in Series D financing in September, bringing cumulative funding to approximately $185 million.
An undisclosed strategic investor, IAG Capital Partners and Elevage Medical Technologies backed the round.
The company plans commercial expansion of its FFR-CT and Plaque-IQ platform, continued AI research and development, and further clinical studies. The round builds on an existing FDA-cleared Plaque-IQ product.
Use of funds
Accelerate commercial expansion of FFR-CT and Plaque-IQ clinical platform
Continue AI research and development
Advance clinical studies
Funding history
Series D · This round$55M